Φορτώνει......
Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy
The discovery of epidermal growth factor receptor (EGFR) mutations and subsequent demonstration of the efficacy of genotype-directed therapies with EGFR tyrosine kinase inhibitors (TKIs) marked the advent of the era of precision medicine for non-small-cell lung cancer (NSCLC). First- and second-gene...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Lung Cancer (Auckl) |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5571822/ https://ncbi.nlm.nih.gov/pubmed/28860885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S119644 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|